| Common Stock, Shares Authorized |
500,000,000 |
shares |
0% |
Q1 2025 |
FY 2025 |
| Common Stock, Shares, Issued |
23,437,500 |
shares |
6.5% |
Q1 2025 |
FY 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q1 2025 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$7,105,085 |
USD |
66% |
Q1 2025 |
FY 2025 |
| Deferred Tax Assets, Valuation Allowance |
$0 |
USD |
|
Q1 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
$140,377 |
USD |
83% |
Q1 2025 |
FY 2025 |
| Operating Lease, Liability |
$160,645 |
USD |
-34% |
Q1 2025 |
FY 2025 |
| Lessee, Operating Lease, Liability, to be Paid |
$168,872 |
USD |
|
Q1 2025 |
FY 2025 |
| Operating Lease, Liability, Current |
$93,719 |
USD |
12% |
Q1 2025 |
FY 2025 |
| Operating Lease, Weighted Average Discount Rate, Percent |
0.04 |
pure |
0% |
Q1 2025 |
FY 2025 |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
$8,227 |
USD |
|
Q1 2025 |
FY 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$31,579 |
USD |
|
Q1 2025 |
FY 2025 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q1 2025 |
FY 2025 |
| Additional Paid in Capital |
$10,420,096 |
USD |
95% |
Q1 2025 |
FY 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$140,377 |
USD |
83% |
Q1 2025 |
FY 2025 |